Lesutype 50 Tablet contains Levosulpiride 50mg, a dopamine D2 receptor antagonist used to improve gastrointestinal motility. It is effective in treating functional dyspepsia, bloating, and delayed gastric emptying, providing relief from digestive discomfort.
Levosulpiride works by blocking dopamine receptors in the gastrointestinal tract, which enhances peristaltic movements, increases lower esophageal sphincter tone, and normalizes gastric and intestinal motility. This helps alleviate nausea, vomiting, and indigestion.
Clinically, Lesutype 50 Tablet is indicated for functional dyspepsia, gastroesophageal reflux disease (GERD), and nausea associated with migraine or chemotherapy. Its tablet formulation ensures accurate dosing, reliable absorption, and convenient administration, promoting better adherence.
Regular use under medical supervision helps in improving digestion, reducing gastrointestinal discomfort, and enhancing nutrient absorption. Lesutype 50 Tablet is a trusted prokinetic therapy, offering safe and effective management of gastrointestinal motility disorders.